|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / December 2008 / December 4, 2008 Two-drug BP therapy can prevent heart attack, stroke |
Exercise may not be key to weight loss
How sleep apnea increases the risk of stroke-related death
Diabetic men have similar long-term mortality risks as males with heart disease
Childhood disease unlikely to have killed Travoltas son, say docs
Indian-origin researcher identifies gene that predicts heart attack risk
Sack lunches may not provide adequate nutrients to preschooler
Packing lunch for your child might not be a good idea, for a new study has found that sack lunches may not regularly provide adequate nutrients for the growth and development of young children. ANI
Health-monitoring system helps maintain older adults well-being
Many older adults want to remain active and independent for as long as possible. Now, researchers from University of Missouri suggest that installing health monitoring system can help keep check on the health of the elderly and ensure their privacy. ANI
New drug shows potential to treat angina, other cardiac problems
A compound, designed to prevent chest pains in heart patients, could act as a drug to treat angina and possibly other cardiac pathologies, according to a study on animals. ANI
Doctors are usually advised to begin high blood pressure treatment with a diuretic-based strategy, but now an international study has shown that a different single-pill drug combination could be more effective at preventing cardiovascular events such as heart attacks and strokes.
Washington, Dec 4 : Doctors are usually advised to begin high blood pressure treatment with a diuretic-based strategy, but now an international study has shown that a different single-pill drug combination could be more effective at preventing cardiovascular events such as heart attacks and strokes.
The findings of the randomised study led by a University of Michigan Health System researcher, has actually challenged the way blood pressure is usually treated worldwide.
The researchers in the ACCOMPLISH study compared two drug combinations and the results turned out to be so significant that the trial was stopped early.
Both single-pill combination drugs helped more than 75 percent of people who had high blood pressure and other cardiovascular risk factors get their blood pressure down.
In fact, more importantly, patients in the study taking the combination that included a calcium channel blocker had 20 percent fewer heart-related events than the patients taking the other combination.
For the study, a total of 11,506 study participants took a single tablet that includes two medications. One group received a tablet containing benazepril, which is a type of drug called an ACE inhibitor, and amlodipine, which belongs to a class of drugs known as calcium channel blockers or CCBs. The other pill combined benazepril and hydrochloro-thiazide, a type of diuretic or "water pill."
Scientists observed a 20 percent reduction in cardiovascular events with the ACE/CCB combination tablet.
Currently, national guidelines for the treatment of high blood pressure (also called hypertension) call for patients who need medication to start out on a single pill, usually a diuretic, or water pill, and to add other drugs only as needed to bring pressure down.
However, the new results may actually change those guidelines. The new study suggests physicians no longer give diuretics preferred status in treating patients.
"This robust study showed us that switching patients to a single-pill combination meant that twice as many patients got to their blood pressure goal, regardless of previous therapy," said University of Michigan Health System's Kenneth Jamerson, M.D., the leader of the study.
He added: "The significant reduction in cardiovascular events we observed in patients will, I hope, show physicians that earlier use of a combination medication, especially with amlodipine, may be in the best interest of patients," he says. The study results have shown that just six months of treatment with either drug combination was enough to bring the blood pressure of 73 percent of patients into an acceptable range.
The drop in blood pressure was despite the fact that two-thirds were already taking some other medication before they entered the study.
The study has appeared in the latest edition of New England Journal of Medicine.
ANI
